Join
Live feed
·
INSIDERFilingvia Quantisnow
Wave Life Sciences Ltd. logo

Director Rawcliffe Adrian sold $67,183 worth of shares (12,700 units at $5.29) as part of a pre-agreed trading plan, closing all direct ownership in the company (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
WVE· Wave Life Sciences Ltd.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track WVE (Wave Life Sciences Ltd.) and more on Quantisnow.